Mourad G, Mimran A, Mion C M
Nephron. 1985;41(2):166-9. doi: 10.1159/000183574.
Recovery of renal function to a self-sustaining level was observed in 4 patients with accelerated malignant hypertension who required chronic hemodialysis therapy. Excellent blood pressure control was achieved in all the patients on captopril therapy. Hemodialysis could be discontinued after 2-9 months of captopril therapy; on recovery of renal function levels of creatinine clearance became stable ranging from 28 to 56 ml/min within 5-15 months of captopril treatment, and remained at this level during 21-64 months of observation. The management of hypertension and the inhibition of the renin-angiotensin system afforded by chronic angiotensin-converting enzyme inhibition is very promising as a means of reversing the process of malignant nephrosclerosis.
在4例需要长期血液透析治疗的急进性恶性高血压患者中,观察到肾功能恢复到了自我维持水平。所有接受卡托普利治疗的患者血压均得到了良好控制。卡托普利治疗2至9个月后可停止血液透析;卡托普利治疗5至15个月内,肾功能恢复后肌酐清除率水平稳定在28至56 ml/分钟,在21至64个月的观察期内保持这一水平。长期应用血管紧张素转换酶抑制剂对高血压的控制以及肾素-血管紧张素系统的抑制,作为逆转恶性肾硬化进程的一种手段,前景十分广阔。